Skip to search formSkip to main contentSkip to account menu

Buserelin

Known as: Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, (Des-Gly10,D-Ser(tBu)6,Pro-NHEt9)-LHRH, Busereline 
A synthetic analog of gonadotropin-releasing hormone (GnRH). Buserelin binds to and activates pituitary gonadotropin releasing hormone (GnRH… 
National Institutes of Health

Related topics

Related topics

15 relations
Buserelin AcetateIn Bloodagonistsanalogs & derivatives

Broader (1)

Fertility Agents, Female

Narrower (4)

HOE-766ReceptalSuprecurSuprefact

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
N-Trimethylated Chitosan Chloride (TMC) Improves the Intestinal Permeation of the Peptide Drug Buserelin In Vitro (Caco-2 Cells) and In Vivo (Rats)
AbstractPurpose. To evaluate N-trimethyl chitosan chloride (TMC) of highdegrees of substitution as intestinal permeation… 
Highly Cited
2002
Highly Cited
2002
Comparison of two Ovsynch protocols (GnRH versus LH) for fixed timed insemination in buffalo (Bubalus bubalis).
Highly Cited
2002
Highly Cited
2002
Follicular recruitment and ovulatory response to FSH treatment initiated on day 0 or day 3 postovulation in goats.
Highly Cited
1994
Highly Cited
1994
The effect of a GnRH analogue on the dynamics of follicular development and synchronization of estrus in lactating cyclic dairy cows.
Highly Cited
1994
Highly Cited
1994
Effect of buserelin on pregnancy rates in dairy cows
Three field trials were carried out to assess the effect of buserelin on the fertility of dairy cows. In the first, 10 micrograms… 
Highly Cited
1994
Highly Cited
1994
Influence of corpus luteum and induced ovulation on ovarian follicular dynamics in postpartum cyclic cows treated with buserelin and cloprostenol.
The influence of the corpus luteum (CL) at the time of buserelin treatment and of buserelin-induced ovulation on the dynamics of… 
Highly Cited
1993
Highly Cited
1993
Treatment with α-helical-CRF(9–41) prevents the anorectic effect of 17-β-estradiol
1992
1992
Buserelin in premenstrual syndrome.
Buserelin, a luteinizing hormone releasing hormone agonist was administered nasally in doses of 900 micrograms daily to inhibit… 
Highly Cited
1985
Highly Cited
1985
LHRH-agonist treatment in clinical and experimental human breast cancer.
Highly Cited
1980
Highly Cited
1980
The calcium requirement in GnRH-stimulated LH release is not mediated through a specific action on receptor binding.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)